Latest Breaking News On - Zeteo zeox - Page 1 : comparemela.com

Zeteo s patient-centric needle free nasal delivery systems are commercially scalable to facilitate rapid deployment of drugs and vaccines

Zeteo s patient-centric needle free nasal delivery systems are commercially scalable to facilitate rapid deployment of drugs and vaccines
massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesZeteo zeoxNational newsZeteo biomedicalMassachusetts newswireForm fill seal

Zeteo Biomedical LLC Introduces OrionMRQ Nasal Delivery Device for Drugs and Vaccines

eNewsChannels NEWS: Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo's latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route. :: News from eNewsChannels

United statesZeteo zeoxZeteo biomedicalForm fill seal

Sublingual Delivery Device for Vaccines & Pharma from Zeteo Biomedical Receives US Patent

Sublingual delivery is an emerging strategy for vaccines AUSTIN, Texas /Massachusetts Newswire – National News/ Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent 10238577). This latest patent expands the capabilities of Zeteo’s ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route. Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain, cardiovascular, allergy, seizure, sedation and emesis. The sublingual route avoids first pass metabolism and provides rapid systemic uptake into the body providing advantages over traditional oral medications.

United statesZeteo zeoxCathy diehlTimothy sullivanNational newsZeteo biomedicalMassachusetts newswireUnited states patentDelivery deviceDelivery platformஒன்றுபட்டது மாநிலங்களில்கேத்தி டீல்தீமோத்தேயு சல்லிவன்தேசிய செய்திஒன்றுபட்டது மாநிலங்களில் காப்புரிமைடெலிவரி சாதனம்

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals

Sublingual delivery is an emerging strategy for vaccines

United statesZeteo zeoxTimothy sullivanMedia contact cathy diehl zeteo biomedicalZeteo biomedicalUnited states patentDelivery deviceDelivery platformAssociated pressNation worldஒன்றுபட்டது மாநிலங்களில்தீமோத்தேயு சல்லிவன்ஒன்றுபட்டது மாநிலங்களில் காப்புரிமைடெலிவரி சாதனம்டெலிவரி நடைமேடைதொடர்புடையது ப்ரெஸ்

Zeteo Biomedical Receives US Patent for its Sublingual Delivery Device for Vaccines and Pharma

eNewsChannels NEWS: Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route. :: News from eNewsChannels

United statesZeteo zeoxCathy diehlTimothy sullivanZeteo biomedicalUnited states patentDelivery deviceDelivery platformஒன்றுபட்டது மாநிலங்களில்கேத்தி டீல்தீமோத்தேயு சல்லிவன்ஒன்றுபட்டது மாநிலங்களில் காப்புரிமைடெலிவரி சாதனம்டெலிவரி நடைமேடை